Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau

Overview of attention for article published in Alzheimer's Research & Therapy, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news: 2 news outlets

twitter: 1 X user

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau.

Alzforum, 09 Aug 2019

Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A…

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model ...

Medical Health News, 02 Aug 2019

Animals and study design All experiments were carried out in compliance with the German national guidelines for animal…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.